Murine T cells expressing Va5 are characterized by (a) intrathymic deletion in the presence of I-E and products of endogenous mouse mammary tumor viruses, and (b) a greater representation in CD8 § relative to CD4 + peripheral T cells, thought to be due to more efficient intrathymic positive selection on class I rather than class II major histocompatibility complex antigens. We have engineered mice that are transgenic for a rearranged gene encoding a Va5 + B chain of the T cell receptor for antigen. Deletion is not predicted in I-E-Va5 + transgenic mice, and until the age of 2 wk, the CD4/CD8 ratio of peripheral T cells is >3:1 and indistinguishable between transgenic and nontransgenic mice. Transgenic mice then show a rapid, age-dependent decline in the ratio of CD4 + to CD8 + T cells in the lymphoid periphery, reaching a low of 1:10 by 7 mo of age. Furthermore, the percent of peripheral CD4 + cells that express the transgene drops with age, reaching a low of about 60% at 7 mo, while the percent of CD8 + cells that express Va5 remains greater than 95% at all ages. The lymphoid periphery is implicated in this selection against CD4 + Va5 + T cells as it occurs more rapidly in thymectomized transgenic mice, and can be delayed in mice whose peripheral T cells are replaced by recent thymic emigrants after depletion by in vivo treatment with anti-Thy-1 antibodies. These results indicate that the relative expression of Va5 in T cell subsets can be influenced not only intrathymically in I-E+Va5 + transgenic mice, but also by events in the periphery, in the absence of I-E expression. though helper and cytotoxic T cells differ in function, accessory molecule expression, MHC restriction specificity, and antigen recognition, they express largely overlapping V~ and Va TCR genes. One apparent exception to this rule is the observation that V~5 expression is lower among CD4 + compared with CD8 + T cells in mice that do not express I-E (1, 2). Thus, in an adult C57BL/6 mouse, "~10-12% of CD8 + peripheral T cells are Va5 § , compared with only 3-5% of CD4 + peripheral T cells. This skewed Va expression has been documented for both functional members of the Va5 family, Va5.1 and Va5.2 (2), and has been taken to mean that regardless of the coexpressed ce chain, cells expressing V~5 + TCIL are more efficiently positively selected on class I than on class II MHC (2).
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Other studies have indicated that Va5.1 + and Va5.2 + cells are deleted intrathymically in mice that express I-E molecules and a "cotolerogen," originally named Etc-1 (3) . Intrathymic deletion in this (2) and many other cases (see reference 4 for review) results in the elimination of cells of both CD4 + and CD8 + phenotypes expressing high levels of TCR, suggesting the signal for deletion is delivered to a thymocyte population bearing both accessory molecules. It is now known that Etc-1 encodes an endogenous mammary tumor provirus (Mtv), Mtv-9, and that the open reading frame of the 3' long terminal repeat of this defective viral integrant encodes the "self~'-determinant that deletes Va5 + cells in I-E + mice (5, 6) . A second endogenous retroviral integrant, Mtv-6, has recently been implicated in I-E-mediated deletion of V~5.1 + and V~5.2 + TCK (7) .
To study the expression of V~5 in T cells in I-E + and I-E-mice and the relationship between Va5 expression and CD4 and CD8 positivity, we engineered mice transgenic for a rearranged V~5.2 ~ chain of the TCK (8). Our work illustrates that chronic selective forces can operate on mature T cells after they have left the thymus.
Materials and Methods
Mice. V~5 + transgenic mice were derived on a congenic C57BL/6 background (H-2K b § I-E-, Mtv-6-, Mtv-9 +) by injection of a rearranged genomic fl chain gene from the CD8 + cytotoxic T cell clone B3, specific for chicken OVA and H-2K b (9). This 3 chain gene consists of V~5.2/D~2/Ja2.6 and includes the endogenous promoter and enhancer. Two lines of independently derived mice were used throughout these studies, both carrying 5-10 copies of the transgene, and both transmitting the transgenes in a Mendelian fashion (8) . V~5 + transgenic mice were maintained as heterozygotes by crossing with C57BL/6 females purchased from The Jackson Laboratory (Bar Harbor, ME). Weanlings were screened for transgene expression in PBL using a mAb specific for VaS.1 and Vt~5.2 (10) . Control nontransgenic mice were offspring from these same matings. I-E § + transgenic mice were derived by mating heterozygous Va5 transgenic mice with line 107-1 (11), a line of E~ transgenic mice demonstrating a normal pattern of transgene expression. PBL from offspring were screened for cell surface expression of both Va5 and I-E.
Surgery. Mice were anesthetized with tri-bromoethanol and either their thymuses were removed by suction or their cervical lymph nodes were removed by dissection. Wounds were closed by suture or wound clips.
Cell Separation. PBL were isolated by water lysis of whole heparinized blood. Cortisone-resistant thymocytes were removed from animals 2 d after intraperitoneal injection of 5 mg of hydrocortisone acetate in ethanol and water. Care was taken to remove the thymus free of neighboring lymph nodes. Lymph node cells were derived from inguinal, brachial, axial, cervical, and mesenteric lymph nodes.
Antibodies and ln Vivo TCellDepletion. MR9-4, a murine IgG mAb specific for Vt~5.1 and V~5.2 (10), and H7-597, an Armenian hamster antibody specific for the murine TCR 3 chain (12), were purified from ascites (MR9-4) or culture supematant (H7-597) over protein G columns and directly conjugated with fluorescein as described (13) . PE-conjugated anti-mouse IgG1 was purchased from Southern Biotechnology Associates, Inc. (Birmingham, AL). Fluorescein-conjugated anti-mouse I-E (clone AMS-16), PEconjugated anti-CD4, and FITC-and PE-conjugated anti-CD8 were purchased from PharMingen (San Diego, CA). T24, a rat antiThy-1 mAb (14) , was used as unpurified ascites for the in vivo elimination of peripheral T cells. In vivo titration ofT24 was performed by intraperitoneal injection of graded doses of unpurified ascites once or twice into C57BL/6 mice. The e~cacy of T cell elimination was judged by analysis of lymph node ceUs removed 3-5 d after the last injection. Cells were stained with anti-T cell reagents (anti-Thy-1, anti-CD4, anti-CDS, H7-597) and analyzed by flow cytometry. Cells were also assayed for their ability to proliferate to the T cell mitogen Con A. A >10-fold decrease in the number and proliferative capacity of T cells from injected mice was achieved using the following protocol. Animals of the indicated ages were prebled, injected intraperitoneally with 100 gtl of unpurified T24 ascites, rested 1 d, given a second injection of 100/~l of ascites, and bled again 5 d later to test the effectiveness of the treatment. In each experiment, thymectomized transgenic and nontransgenic animals were also treated to test the dependence of T cell recovery on a functional thymus. 
Antibody Staining and Cell Analysis.

Results and Discussion
The CD4/CD8 Ratio in T Cells from Young V~5 Transgenic Mice Is Indistinguishable from That in Young Nontransgenic
Animals. The preferential expression of Vt~5 among CD8 + relative to CD4 § peripheral T cells in I-E-strains of mice led us to analyze the ratio of CD4 + to CD8 + T cells in Va5 + TCR transgenic mice. Not surprisingly, while the CD4/CD8 ratio in PBL from 12-wk-old nontransgenic animals is ~3, that of PBL from age-matched transgenic littermates is <0.4 ( Fig. 1 a) . These differences are equally apparent in peripheral T cells from spleen and lymph node (data not shown) as well as PBL. In contrast to these data from adult animals, in pups from 5 d to 2 wk of age, the ratio of CD4 to CD8 expression in spleen cells from transgenic and nontransgenic animals is indistinguishable. The CD4/ CD8 ratio in the eight transgenic and eight nontransgenic 5-d-old pups examined was 6.3 and 7.1, respectively. At 7 d, two pups of each type were examined, with an average ratio of 5.6 for transgenic and 5.7 for nontransgenic. The average ratios for 13-d-old pups were 1.8 (for seven transgenic pups) and 2.3 for (three nontransgenic pups), with the disparity between transgenic and nontransgenic mice increasing thereafter. Aside from the initial drop in the ratio of CD4 to CD8 expression during the first few weeks after birth, the mean ratio in nontransgenic mice is relatively constant, at ",~2-3:1. In contrast, transgenic mice are characterized by high CD4/CD8 ratios in young animals that drop >30-fold to a low of 0.1 at ,,o7 mo of age (Fig. 1 a) . The age-dependent decline in the ratio of CD4/CD8 expression seems to be a result of a decrease in the number of CD4 + T cells rather than an increase in the number of CD8 + T cells. The number of CD8 + lymph node cells is relatively constant between age-matched transgenic and nontransgenic mice, while the number of CD4 + cells is much lower in the transgenic animals (data not shown).
The CD4 + Population of Peripheral T Cells in Transgenic Animals Shows a Marked, Age-related Decrease in VB5 Expression, while the CD8 + Population Does Not.
We analyzed the expression of Va5 in CD4 + and CD8 + T cells in transgenic animals from the ages of 5 d to 45 wk (Fig. 1 b) . In animals 2 mo of age and younger, >95% of both CD4 + and CD8 + populations of peripheral T cells are V~5 + by surface staining. As these animals age, there is no detectable change in the transgene expression in CD8 § T cells; however, there is a marked decrease in the percent of CD4 + cells that express the transgene. By 6 mo of age, as few as 60% of CD4 + peripheral T cells from transgenic animals are V~5 § (Fig. 1 b) . Most of the remaining '~40% of CD4 + cells express a TCR oe//~ as judged by bright staining with H7-597 (data not shown). in Fig. 2 a, it is clear that the mature, Vfl5 high population of thymocytes is deleted in I-E+V~5+Mtv-9 + transgenic mice but not in their I-E-counterparts. These data are in agreement with previous work showing that in mice expressing both Mtv-9 and I-E, deletion of V05 + cells occurs in the thymus, at the time of transition from the TCR duu, CD4 + CD8 + to the TCR high, CD4 + or CD8 + stage (2). The incomplete, slow deletion of CD4 + V05 + ceils in I-Etransgenic animals does not occur at this same stage of development. Furthermore, the CD4/CD8 ratio of"mature" cortisoneresistant thymocytes pooled from two 33-wk-old transgenic mice is 1.9, similar to the value of 2.4 obtained from a pool of two age-matched nontransgenic animals (Fig. 2 b) . In contrast, lymph node cells from untreated littermates showed the expected decrease in the ratio of CD4/CD8 in the transgenie (0.2) compared with the nontransgenic animal (1.4) . In 33-wk-old transgenic animals, 97% of CD4+CD8 -thymocytes are VO5 +, while only 79% of CD4 + lymph node cells are Va5 + (data not shown).
We next sought direct evidence that the lymphoid periphery influences the percent of CD4 + transgene-expressing T cells. We analyzed both the CD4/CD8 ratio and V#5 expression in transgenic animals that had been thymectomized at 6 wk of age. By analyzing these parameters at increasing times after thymectomy, we can observe what happens when peripheral T calls "age;' in the absence of recent thymic emigrants. In adult thymectomized animals, the percent of CD4 + PBL that express the transgene decreases dramatically, reaching a low of <40%, compared with a low of 70% for agematched nonthymectomized control transgenics (Fig. 3 a) . As in nonthymectomized animals, the percent of CD8 + cells that are V05 § remains uniformly high, at >95% (data not shown). Thus, thymectomy appears to accelerate the deletion of CD4 + V/)5 + T cells, while having no effect on Va5 expression in CD8 § cells.
In of the TCR (17) have led to the suggestion that while allelic exclusion of oe chain genes is leaky, that of 3 chain genes is nearly absolute. Our finding that up to 40% of peripheral CD4 + T cells in old but otherwise unmanipulated 3 chain transgenic animals can express endogenously rearranged/3 chain genes is indicative of the power of the peripheral selection we have analyzed. Use of endogenous c~ and 3 chain genes has recently been documented in TCR oe/3 transgenic mice bearing inappropriate MHC molecules (18) . The selection against CD4+Va5 + cells is not an idiosyncracy of the particular transgene we have chosen to study, since both Va5.1 and Va5.2 expression decline with age in CD4 + but not CD8 + peripheral T cells from nontransgenic animals (data not shown). In vivo anti-Thy-1 treatment implicates the lymphoid periphery in this selection, just as in transgenic mice (data not shown).
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Figure 2. I-E-V~5 transgenic mice do not delete CD4 + V~5 + cells intrathymically. (a) Thymocytes from 5-wk-old I-E + (top) and I-E-(bottom)
Why then are the CD4+Va5 + cells selected against? Our unpublished observations that expression of the memory cell marker Pgp-1 (19) is high among CD4+Va5 + T cells in transgenic mice, and that these cells are mildly anergic to signals through their TCR, have suggested that CD4 + Va5 + cells may be stimulated by their antigen, rendered anergic, and then disappear (20) . One candidate antigen is Mtv-9, already well documented to delete Vt35 + thymocytes in I-E + animals (5-7, and Fig. 2 a) . Perhaps in the absence of I-E, Mtv-9 no longer mediates intrathymic deletion (of both CD4 + and CD8 + single-positive cells) but instead causes the progressive, peripheral deletion of CD4 + cells that we see. We are currently deriving I-E-Mtv-6/9-Va5 + transgenic mice to test this hypothesis.
Can Selection against CD4+V#5 + Peripheral Cells Wholly
Account for the Skewed Expression of V#5 among CD8 + Relative to CD4 + Peripheral Cells? If this skewed expression is due solely to the weak positive selection of Va5 + TCR on class II relative to class I MHC, one would predict that this skewing would be stable, without regard for the age of the animal in question. Our results add another level of complexity to this picture, but do not rule out the notion of the enhanced positive selection of Va5 + TCR on class I. Even as early as day 5 of neonatal life, Ve5 expression is skewed toward the CD8 + population of peripheral T cells in nontransgenic mice (data not shown). Furthermore, in 11-and 33-wk-old nontransgenic animals there is an enhanced expression of Va5 in hydrocortisone-resistant CD8 + relative to CD4 + thymocytes (,,o15% vs. 5%; data not shown). These data are in agreement with the notion that class II is ineff~dent at positively selecting Va5 + TCR intrathymically, and suggest that class II and some peripherally expressed antigen also serve to modulate the TCR. repertoire of mature T cells. This latter means of manipulating the expressed repertoire of TCR can cause profound alterations in the population of T cells available during the lifetime of the animal.
